Autoimmune Encephalitides: A Broadening Field of Treatable Conditions
Neurologist 22:1-13, Kalman, B., 2017
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Cerebral Venous Thrombosis
NEJM 385:59-64, Ropper, A.H. & Kline, J.P., 2021
Vaccine-Preventable Infections and Immunization in Multiple Sclerosis
Neurol 93:584-594, Farez, M.F.,et al, 2019
Subarachnoid Hemorrhage
NEJM 377:257-266, Lawton, M.T. & Vates, G.E., 2017
Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Evidence-Based Guideline Update: Plasmapheresis in Neurologic Disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 76:294-300, Cortese,I.,et al, 2011
Chronic Fatigue Syndrome or Myalgic Encephalomyelitis
BMJ 335:411-412, White,P.,et al, 2007
Recommended Diagnostic Criteria for Paraneoplastic Neurological Syndromes
JNNP 75:1135-1140,1090, Graus,F.,et al, 2004
Immunization and MS
Neurol 59:1837-1843, Rutschmann,O.T.,et al, 2002
Assessment:Neurologic Risk of Immunization, Report of the Therapeutics and Technology Assessment Subcommittee of the AAN
Neurol 52:1546-1552, Fenichel,G.M., 1999
Results of a Computerized Screening of Stroke Patients for Unjustified Hospital Stay
Stroke 27:639-644, Goldman,R.S.,et al, 1996
Guidelines on the Detection of Paraneoplastic Anti-Neuronal-Specific Antibodies
Neurol 45:1937-1941, Moll,J.W.B.,et al, 1995